Claims for Patent: 11,931,463

Summary for Patent: 11,931,463

Title:	All-in-one fixed-dose combination for treating Helicobacter pylori infection
Abstract:	Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by H. pylori or the prevention of recurrence of disorders associated with infection by H. pylori.
Inventor(s):	Reza Fathi, Gilead Raday, Guy Goldberg, Patrick Gosselin
Assignee:	Redhill Biopharma Ltd
Application Number:	US17/408,111
Patent Claims:	1. An all-in-one capsule comprising: about 12.5 mg rifabutin; about 250 mg amoxicillin; and about 10 mg omeprazole, wherein the omeprazole is in the form of a first plurality of minitablets. 2. The solid oral dosage form of claim 1 wherein the omeprazole is an equivalent amount of omeprazole magnesium. 3. The solid oral dosage form of claim 1 wherein the capsule includes a second plurality of minitablets, wherein each minitablet of the second plurality of minitablets comprises a mixture of amoxicillin and rifabutin. 4. The solid oral dosage form of claim 3 wherein the minitablets of the second plurality of minitablets have a size in the range of from about 100 μm to 2 mm. 5. The solid oral dosage form of claim 1 wherein the omeprazole minitablets are coated with a protective coat. 6. The solid oral dosage form of claim 5 wherein the protective coat is an enteric coating. 7. The solid oral dosage form of claim 1 wherein the minitablets of the first plurality of minitablets have a size in the range of from about 100 μm to 2 mm. 8. A packaged pharmaceutical preparation comprising a plurality of the capsules of claim 1 in a sealed container and instructions for administering them to treat a patient infected with H. pylori. 9. The packaged pharmaceutical preparation of claim 8 comprising a 14 day supply of the capsules. 10. A method for treating H. pylori infection comprising orally administering each day, for an effective period of time, a plurality of the all-in-one capsules of claim 1 to a human having an H. pylori infection. 11. The method of claim 10 comprising orally administering each day, for an effective period of time, twelve all-in-one capsules. 12. The method of claim 11 comprising orally administering each day, for an effective period of time, twelve all-in-one capsules, wherein the administering occurs at three different time points throughout the day. 13. The method of claim 10 wherein the effective period of time is 14 days. 14. An all-in-one capsule comprising: about 12.5 mg rifabutin; about 250 mg amoxicillin trihydrate; and about 10 mg omeprazole, wherein the omeprazole is in the form of a first plurality of minitablets. 15. The all-in-one capsule of claim 14, wherein the rifabutin and the amoxicillin trihydrate within the capsule are in the form of a second plurality of minitablets, wherein each minitablet of the second plurality of minitablets comprises a mixture of the rifabutin and the amoxicillin trihydrate.